Gordian Biotechnology Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 40

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 30

Gordian Biotechnology General Information

Description

Developer of a gene therapy discovery platform designed to improve research for complex diseases related to aging. The company's platform researches and develops therapeutic drugs that can prevent premature aging in humans, enabling doctors to cure age-related diseases and patients to improve their skin conditions.

Contact Information

Website
www.gordian.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 486 Cabot Road
  • Gordian Biotechnology
  • South San Francisco, CA 94080
  • United States
+1 (714)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 486 Cabot Road
  • Gordian Biotechnology
  • South San Francisco, CA 94080
  • United States
+1 (714)

Gordian Biotechnology Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gordian Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 01-Jun-2025 Completed Product Development
7. Accelerator/Incubator 29-Apr-2025 Completed Product Development
6. Later Stage VC 26-Apr-2024 Completed Product Development
5. Secondary Transaction - Private Completed Product Development
4. Early Stage VC (Series A) 10-Dec-2021 Completed Product Development
3. Seed Round 21-Apr-2020 Completed Product Development
2. Accelerator/Incubator 01-Jan-2019 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Gordian Biotechnology’s complete valuation and funding history, request access »

Gordian Biotechnology Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-4
Series A-3
Series A-2
Series A-1
Seed-2
Seed-1 183,297 $0.000010 6% $0.74 $0.74 1x $0.74 0.65%
Seed 4,011,137 $0.000010 6% $1.02 $1.02 1x $1.02 14.29%
To view Gordian Biotechnology’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Gordian Biotechnology Patents

Gordian Biotechnology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026187921-A1 Serpina1 methods and compositions Pending 04-Mar-2025
EP-4330400-A1 Compositions and methods for in vivo screening of therapeutics Pending 26-Apr-2021
EP-4330400-A4 Compositions and methods for in vivo screening of therapeutics Pending 26-Apr-2021
US-20240200229-A1 Compositions and methods for in vivo screening of therapeutics Pending 26-Apr-2021
WO-2022232054-A1 Compositions and methods for in vivo screening of therapeutics Inactive 26-Apr-2021 C12Q1/6897
To view Gordian Biotechnology’s complete patent history, request access »

Gordian Biotechnology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Gordian Biotechnology Investors (30)

Investor Name Investor Type Holding Investor Since Participating Rounds
K5 Global Venture Capital Minority
Starbloom Capital Venture Capital Minority
Charles River Incubator Program Accelerator/Incubator
Arctic Ventures Venture Capital Minority
Athos Service Family Office Minority
You’re viewing 5 of 30 investors. Get the full list »

Gordian Biotechnology FAQs

  • When was Gordian Biotechnology founded?

    Gordian Biotechnology was founded in 2018.

  • Where is Gordian Biotechnology headquartered?

    Gordian Biotechnology is headquartered in South San Francisco, CA.

  • What is the size of Gordian Biotechnology?

    Gordian Biotechnology has 40 total employees.

  • What industry is Gordian Biotechnology in?

    Gordian Biotechnology’s primary industry is Drug Discovery.

  • Is Gordian Biotechnology a private or public company?

    Gordian Biotechnology is a Private company.

  • What is Gordian Biotechnology’s current revenue?

    The current revenue for Gordian Biotechnology is .

  • How much funding has Gordian Biotechnology raised over time?

    Gordian Biotechnology has raised $60M.

  • Who are Gordian Biotechnology’s investors?

    K5 Global, Starbloom Capital, Charles River Incubator Program, Arctic Ventures, and Athos Service are 5 of 30 investors who have invested in Gordian Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process